Pneumatic compression device treatment of lower extremity lymphedema elicits improved limb volume and patient-reported outcomes

S. C. Muluk, A. T. Hirsch, E. C. Taffe

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Objectives Examine the effectiveness of an advanced pneumatic compression device (APCD) in reducing limb volume (LV), and to evaluate clinician and patient-reported outcomes. Design Device registry study. Materials and methods Data were collected prospectively for 196 lower extremity lymphedema patients prescribed an APCD. Baseline and post-treatment LVs were calculated and clinical outcomes (skin changes, pain, and function) were assessed. Patient-reported outcomes and satisfaction utilizing a pre- and post-treatment survey were also evaluated. Results 90% of APCD-treated patients experienced a significant reduction in LV with 35% enjoying a reduction >10%. Mean LV reduction was 1,150 mL or 8% (p <.0001). Greater baseline LV and BMI were strong predictors of LV reduction (p <.0001). Clinician assessment indicated that the majority of patients experienced improvement in skin fibrosis and function. Patient-reported outcomes showed a significant increase in ability to control lymphedema through APCD treatment, with an increase in function and a reduction in the interference of pain. 66% were "very satisfied" with the APCD treatment. Conclusion APCD use is associated with consistent reductions in LV, with favorable patient-reported outcomes. Results demonstrate that reduction in LV and pain, combined with functional improvement and patient satisfaction can be achieved, providing tangible benefit for lower extremity patients.

Original languageEnglish (US)
Pages (from-to)480-487
Number of pages8
JournalEuropean Journal of Vascular and Endovascular Surgery
Volume46
Issue number4
DOIs
StatePublished - Oct 1 2013

Keywords

  • Lymphedema
  • Pneumatic compression device
  • Quality of life

Fingerprint Dive into the research topics of 'Pneumatic compression device treatment of lower extremity lymphedema elicits improved limb volume and patient-reported outcomes'. Together they form a unique fingerprint.

Cite this